Invention Grant
- Patent Title: Application and uses of PRG4 and therapeutic modulation thereof
-
Application No.: US13321532Application Date: 2010-05-24
-
Publication No.: US09730865B2Publication Date: 2017-08-15
- Inventor: Benjamin Sullivan , Edward R. Truitt , David Sullivan
- Applicant: Benjamin Sullivan , Edward R. Truitt , David Sullivan
- Applicant Address: US MA Framingham US MA Boston
- Assignee: Lubris, LLC,Schepens Eye Research Institute
- Current Assignee: Lubris, LLC,Schepens Eye Research Institute
- Current Assignee Address: US MA Framingham US MA Boston
- Agency: Goodwin Procter LLP
- International Application: PCT/US2010/035956 WO 20100524
- International Announcement: WO2010/135736 WO 20101125
- Main IPC: A61B17/24
- IPC: A61B17/24 ; A61K8/02 ; A61L27/50 ; A61K8/64 ; A61K8/73 ; A61K9/00 ; A61K31/728 ; A61Q11/00 ; A61Q19/00 ; A61K36/886 ; A61K38/17 ; C07K14/47 ; C07K14/435 ; A61K9/68
Abstract:
The present invention relates to the uses of the protein PRG4 and therapeutic modulation thereof. In particular, the present invention relates compositions and methods utilizing PRG4 and therapeutic modulation thereof, including, use as a surgical lubricant, use in a treatment for prevention or reduction of post-surgical adhesions, use in a treatment for oral ulcerations, use as an athletic lubricating patch, use as a dermal filler, use in a treatment for dry mouth, use in a drug delivery method or composition, and use in nursing lubrication.
Public/Granted literature
- US20120134925A1 Application and Uses of PRG4 and Therapeutic Modulation Thereof Public/Granted day:2012-05-31
Information query
